Medicare policies governing cancer patients’ end-of-life care are based on generalized statistics—such as average survival time and treatment costs—that often fail to reflect the variety of experiences across patient subpopulations, as well as among individual patients according to a new study led by Harvard Medical School researchers, published in the July issue of the journal Health Affairs.
Sharon-Lise Normand, co-chair of a National Academies of Science panel to study monitoring of motor carriers in the United States, briefed congressional staff on June 26, 2017.
In the first June 2017 issue of the New England Journal of Medicine, Joseph Newhouse and Sharon-Lise Normandpublished a review of health policy trialsas part of the Journal’s series involving The Changing Face of Clinical Trials.
Ahead of the Annual Research Meeting, AcademyHealth announced the winners of their various research awards. Included among the names were several HCP former students and faculty.
Sharon-Lise Normand was selected to give the Marvin Zelen Keynote Address at the joint meeting of the Eastern Mediterranean and the Italian Regions of the International Biometrics Society held in May in Thessaloniki, Greece.
Michael McWilliams was the keynote speaker at the 21st Annual Kovner-Behrman Health Forum at the NYU Wagner Graduate School of Public Service, with a talk titled “Accountable Care Organizations: Making Progress in a Land of Unicorns.”
